These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 32935873)

  • 1. Invited Review: The spectrum of neuropathology in COVID-19.
    Al-Sarraj S; Troakes C; Hanley B; Osborn M; Richardson MP; Hotopf M; Bullmore E; Everall IP
    Neuropathol Appl Neurobiol; 2021 Feb; 47(1):3-16. PubMed ID: 32935873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuro-COVID-19: an insidious virus in action.
    Bratosiewicz-Wąsik J
    Neurol Neurochir Pol; 2022; 56(1):48-60. PubMed ID: 34642927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging neurotropic features of SARS-CoV-2.
    Zhan WR; Huang J; Zeng PM; Tian WY; Luo ZG
    J Mol Cell Biol; 2021 Dec; 13(10):705-711. PubMed ID: 34289037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review of Neurological Involvement in Patients with SARS-CoV-2 Infection.
    Xu Y; Zhuang Y; Kang L
    Med Sci Monit; 2021 Jun; 27():e932962. PubMed ID: 34145211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Encephalitic syndrome and anosmia in COVID-19: Do these clinical presentations really reflect SARS-CoV-2 neurotropism? A theory based on the review of 25 COVID-19 cases.
    Pouga L
    J Med Virol; 2021 Jan; 93(1):550-558. PubMed ID: 32672843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19-related neuropathology and microglial activation in elderly with and without dementia.
    Poloni TE; Medici V; Moretti M; Visonà SD; Cirrincione A; Carlos AF; Davin A; Gagliardi S; Pansarasa O; Cereda C; Tronconi L; Guaita A; Ceroni M
    Brain Pathol; 2021 Sep; 31(5):e12997. PubMed ID: 34145669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 and the brain: A review of the current knowledge on neuropathology in COVID-19.
    Maiese A; Manetti AC; Bosetti C; Del Duca F; La Russa R; Frati P; Di Paolo M; Turillazzi E; Fineschi V
    Brain Pathol; 2021 Nov; 31(6):e13013. PubMed ID: 34390282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of coronavirus infectious disease 2019-related neurologic diseases.
    Klein RS
    Curr Opin Neurol; 2022 Jun; 35(3):392-398. PubMed ID: 35283461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurological Sequelae in Patients with COVID-19: A Histopathological Perspective.
    Fisicaro F; Di Napoli M; Liberto A; Fanella M; Di Stasio F; Pennisi M; Bella R; Lanza G; Mansueto G
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33546463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 and its effects on neurological functions.
    Yew MMT; Lip JQ; Ling APK
    Trop Biomed; 2021 Sep; 38(3):435-445. PubMed ID: 34608117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological complications and infection mechanism of SARS-COV-2.
    Wan D; Du T; Hong W; Chen L; Que H; Lu S; Peng X
    Signal Transduct Target Ther; 2021 Nov; 6(1):406. PubMed ID: 34815399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.
    Zhou Z; Kang H; Li S; Zhao X
    J Neurol; 2020 Aug; 267(8):2179-2184. PubMed ID: 32458193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathology and Inflammatory Cell Characterization in 10 Autoptic COVID-19 Brains.
    Colombo D; Falasca L; Marchioni L; Tammaro A; Adebanjo GAR; Ippolito G; Zumla A; Piacentini M; Nardacci R; Del Nonno F
    Cells; 2021 Aug; 10(9):. PubMed ID: 34571912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroinvasive potential of SARS-CoV2 with neuroradiological and neuropathological findings: is the brain a target or a victim?
    Franca RA; Ugga L; Guadagno E; Russo D; Del Basso De Caro M
    APMIS; 2021 Feb; 129(2):37-54. PubMed ID: 33098147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological Involvement in COVID-19 and Potential Mechanisms: A Review.
    Aghagoli G; Gallo Marin B; Katchur NJ; Chaves-Sell F; Asaad WF; Murphy SA
    Neurocrit Care; 2021 Jun; 34(3):1062-1071. PubMed ID: 32661794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2: its potential neurological manifestations and plausible mechanism: a review article.
    Taher T; Sheikh AB; Anwar F; Khosa F
    Acta Neurol Belg; 2021 Apr; 121(2):331-339. PubMed ID: 33464546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What can cerebrospinal fluid testing and brain autopsies tell us about viral neuroinvasion of SARS-CoV-2.
    Li YC; Zhang Y; Tan BH
    J Med Virol; 2021 Jul; 93(7):4247-4257. PubMed ID: 33724490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Invasion and Pathological Links to Prion Disease.
    Lukiw WJ; Jaber VR; Pogue AI; Zhao Y
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-Cov-2 infection and neuropathological findings: a report of 18 cases and review of the literature.
    Lebrun L; Absil L; Remmelink M; De Mendonça R; D'Haene N; Gaspard N; Rusu S; Racu ML; Collin A; Allard J; Zindy E; Schiavo AA; De Clercq S; De Witte O; Decaestecker C; Lopes MB; Salmon I
    Acta Neuropathol Commun; 2023 May; 11(1):78. PubMed ID: 37165453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 and Neurology: An Emerging Association.
    Gupta A; Yadav P; Kumar D
    Infect Disord Drug Targets; 2021; 21(8):e160921191570. PubMed ID: 33602080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.